Schmerztherapie bei der onkologischen Patientin und in der Palliativmedizin

Literatur
1 Smith TJ, Temin S, Alesi ER et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012; 30: 880-887
2 van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437-1449
3 Goudas LC, Bloch R, Gialeli-Goudas M et al. The epidemiology of cancer pain. Cancer Investig 2005; 23: 182-190
4 Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008; 19: 1985-1991
5 Maltoni M. Opioids, pain, and fear. Ann Oncol 2008; 19: 5-7
6 Saunders CM. The Management of terminal Disease. London: Arnold; 1978
7 Radbruch L, Loick G, Kiencke P et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Management 1999; 18: 180-187
8 Stiel S, Matthes ME, Bertram L et al. [Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care : the German version of the Edmonton symptom assessment scale (ESAS)]. Schmerz 2010; 24: 596-604
9 Stiel S, Pollok A, Elsner F et al. Validation of the symptom and problem checklist of the German Hospice and Palliative Care Evaluation (HOPE). J Pain Symptom Management 2012; 43: 593-605
10 Grossman SA, Sheidler VR, Swedeen K et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Management 1991; 6: 53-57
11 Pautex S, Herrmann FR, Michon A et al. Psychometric properties of the Doloplus-2 observational pain assessment scale and comparison to self-assessment in hospitalized elderly. Clin J Pain 2007; 23: 774-779
12 Pickering G, Gibson SJ, Serbouti S et al. Reliability study in five languages of the translation of the pain behavioural scale Doloplus. Eur J Pain 2010; 14: 545
13 Basler HD, Hüger D, Kunz R et al. Beurteilung von Schmerz bei Demenz (BESD). Schmerz 2006; 20: 519-526
14 WHO Symptom relief in terminal illness. Geneva: World Health Organization; 1998
15 Raphael J, Ahmedzai S, Hester J et al. Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med 2010; 11: 742-764
16 Heiskanen T, Mätzke S, Haakana S et al. Transdermal fentanyl in cachectic cancer patients. Pain 2009; 144: 218-222
17 Schwarzer A, Nauck F, Klaschik E. [Strong opioids and constipation]. Schmerz 2005; 19: 214-219
18 Wirz S, Wartenberg HC, Nadstawek J. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain. Supportive Care in Cancer 2008; 16: 999-1009
19 Herrinton LJ, Neslund-Dudas C, Rolnick SJ et al. Complications at the end of life in ovarian cancer. J Pain Symptom Management 2007; 34: 237-243
20 Sartori E, Chiudinelli F, Pasinetti B et al. Possible role of palliative surgery for bowel obstruction in advanced ovarian cancer patients. Eur J Gynaecol Oncol 2010; 31: 31-36
21 Klein C, Stiel S, Bukki J, Ostgathe C. [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients: a systematic literature review]. Schmerz 2012; 26: 587-599
22 Radbruch L, Nauck F, Fuchs M et al. What is palliative care in Germany? Results from a representative survey. J Pain Symptom Management 2002; 23: 471-483